Hideki Makishima

13.7k citations

134 papers · 4.0k indexed · h-index 32

Co-authors: Jaroslaw P. Maciejewski Mikkael A. Sekeres Ramón V. Tiu Christine L. O’Keefe Hadrian Szpurka Michael A. McDevitt Bartlomiej Przychodzen Valeria Visconte
Topics: Acute Myeloid Leukemia Research (94 papers)Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers)Chronic Myeloid Leukemia Treatments (21 papers)
Cited by: Hematology Genetics Immunology
Journals: Journal of Clinical Investigation Nature Communications The Journal of Experimental Medicine
Partner nations: United States Japan Germany

In The Last Decade

Hideki Makishima

126 papers receiving 4.0k citations

Peers

Countries citing papers authored by Hideki Makishima

Since Specialization

Citations

This map shows the geographic impact of Hideki Makishima's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hideki Makishima with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hideki Makishima more than expected).

Fields of papers citing papers by Hideki Makishima

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hideki Makishima. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hideki Makishima. The network helps show where Hideki Makishima may publish in the future.

Co-authorship network of co-authors of Hideki Makishima

This figure shows the co-authorship network connecting the top 25 collaborators of Hideki Makishima. A scholar is included among the top collaborators of Hideki Makishima based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hideki Makishima. Hideki Makishima is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Genetic profiles and clinical features in subcutaneous panniculitis‐like T‐cell lymphomas 2024 ·Cancer Science ·(unknown),(unknown),Yasuhito Suehara,(unknown),Yoshiaki Abe,Ryota Matsuoka,Tatsuhiro Sakamoto,Keiichiro Hattori,Yasuhisa Yokoyama,(unknown),Toru Nanmoku,Takeshi Iwasaki,Kenichi Nishiyama,Koji Kato,(unknown),Hideki Makishima,Naoya Nakamura,Shigeru Chiba,Mamiko Sakata‐Yanagimoto	1
2	Founder and subclonal mutations in myelodysplastic syndromes and related myeloid neoplasms 2020 ·Best Practice & Research Clinical Haematology ·Hideki Makishima	2
3	Mutations in Triple-Negative Patients with Myeloproliferative Neoplasms 2019 ·Blood ·(unknown),Paula de Melo Campos,(unknown),(unknown),Tetsuichi Yoshizato,Hideki Makishima,Seishi Ogawa,Sara Teresinha Olalla Saad	3
4	IDH1/2 Mutations Sensitize Acute Myeloid Leukemia to PARP Inhibition and This Is Reversed by IDH1/2-Mutant Inhibitors 2018 ·Clinical Cancer Research ·Remco J. Molenaar,Tomas Radivoyevitch,Yasunobu Nagata,Mohammed Khurshed,(unknown),Hideki Makishima,Mingjiang Xu,Fonnet E. Bleeker,Johanna W. Wilmink,Hetty E. Carraway,Sudipto Mukherjee,Mikkael A. Sekeres,Cornelis J.F. Van Noorden,Jaroslaw P. Maciejewski	79
5	A myeloid tumor suppressor role for NOL3 2017 ·The Journal of Experimental Medicine ·(unknown),(unknown),Boris Bartholdy,Kelly Mitchell,Wendy M. McKimpson,(unknown),Dagmar Walter,Tihomira I. Todorova,Cassandra M. Hirsch,Hideki Makishima,Britta Will,Christine M. McMahon,Kira Gritsman,Jaroslaw P. Maciejewski,Richard N. Kitsis,Ulrich Steidl	11
6	Germline SAMD9 and SAMD9L Alterations in Adult Myelodysplastic Syndromes 2017 ·Blood ·Yasunobu Nagata,Bartlomiej Przychodzen,Cassandra M. Hirsch,Hideki Makishima,(unknown),Babal K. Jha,Teodora Kuzmanovic,Tomas Radivoyevitch,Vera Ademà,Kenichi Yoshida,(unknown),Françesc Solé,Thomas LaFramboise,Rabi Hanna,Mikkael A. Sekeres,Seishi Ogawa,Marcin W. Włodarski,Jörg Cammenga,Jaroslaw P. Maciejewski	3
7	Somatic SETBP1 mutations in myeloid neoplasms 2017 ·International Journal of Hematology ·Hideki Makishima	18
8	Gene mutations in bone marrow failure syndromes. 2016 ·PubMed ·Tetsuichi Yoshizato,Hideki Makishima	1
9	Whole-exome sequencing enhances prognostic classification of myeloid malignancies 2015 ·Journal of Biomedical Informatics ·Matthew Ruffalo,Holleh Husseinzadeh,Hideki Makishima,Bartlomiej Przychodzen,(unknown),Mehmet Koyutürk,Jaroslaw P. Maciejewski,Thomas LaFramboise	9
10	Runx1 repression by histone deacetylation is critical for Setbp1-induced mouse myeloid leukemia development 2015 ·Leukemia ·Bandana Ajay Vishwakarma,(unknown),Hideki Makishima,Naoko Hosono,Kristbjorn O. Gudmundsson,Vir Singh Negi,Kevin Oakley,Yanhua Han,Bartlomiej Przychodzen,J. Maciejewski,Yan Du	33
11	Myeloid Malignancies with Chromosome 5q Deletions Acquire a Dependency on an Intrachromosomal NF-κB Gene Network 2014 ·Cell Reports ·Jing Fang,(unknown),Lyndsey Bolanos,Xiaona Liu,Andrés Jerez,Hideki Makishima,(unknown),Xiaoting Chen,Dinesh S. Rao,H. Leighton Grimes,Kakajan Komurov,Matthew T. Weirauch,José A. Cancelas,Jaroslaw P. Maciejewski,Daniel T. Starczynowski	49
12	Cytogenetic and molecular predictors of response in patients with myeloid malignancies without del[5q] treated with lenalidomide 2012 ·Journal of Hematology & Oncology ·Yuka Sugimoto,Mikkael A. Sekeres,Hideki Makishima,Fabı́ola Traina,Valeria Visconte,Anna Jankowska,Andrés Jerez,Hadrian Szpurka,Christine L. O’Keefe,Kathryn M Guinta,Manuel Afable,Ramón V. Tiu,Kathy L. McGraw,Alan F. List,Jaroslaw P. Maciejewski	18
13	Single Nucleotide Polymorphism Array Lesions, TET2, DNMT3A, ASXL1 and CBL Mutations Are Present in Systemic Mastocytosis 2012 ·PLoS ONE ·Fabı́ola Traina,Valeria Visconte,A. Jankowska,Hideki Makishima,Christine L. O’Keefe,Paul Elson,Yingchun Han,Fred H. Hsieh,Mikkael A. Sekeres,Raghuveer Singh Mali,Matt Kalaycio,Alan Lichtin,Anjali S. Advani,Hien K. Duong,Edward A. Copelan,Reuben Kapur,Sara Teresinha Olalla Saad,Jaroslaw P. Maciejewski,Ramón V. Tiu	86
14	Pathogenesis and Consequences of Uniparental Disomy in Cancer 2011 ·Clinical Cancer Research ·Hideki Makishima,Jaroslaw P. Maciejewski	73
15	Mutations of E3 Ubiquitin Ligase Cbl Family Members Constitute a Novel Common Pathogenic Lesion in Myeloid Malignancies 2009 ·Journal of Clinical Oncology ·Hideki Makishima,Heather Cazzolli,Hadrian Szpurka,Andrew Dunbar,Ramón V. Tiu,Jungwon Huh,Hideki Muramatsu,Christine L. O’Keefe,Eric D. Hsi,Ronald Paquette,Seiji Kojima,Alan F. List,Mikkael A. Sekeres,Michael A. McDevitt,Jaroslaw P. Maciejewski	150
16	FISH and SNP-A karyotyping in myelodysplastic syndromes: Improving cytogenetic detection of del(5q), monosomy 7, del(7q), trisomy 8 and del(20q) 2009 ·Leukemia Research ·Hideki Makishima,(unknown),Lukasz P. Gondek,Jungwon Huh,James R. Cook,Karl S. Theil,Mikkael A. Sekeres,(unknown),Christine L. O’Keefe,Jaroslaw P. Maciejewski	53
17	250K Single Nucleotide Polymorphism Array Karyotyping Identifies Acquired Uniparental Disomy and Homozygous Mutations, Including Novel Missense Substitutions of c-Cbl , in Myeloid Malignancies 2008 ·Cancer Research ·Andrew Dunbar,Lukasz P. Gondek,Christine L. O’Keefe,Hideki Makishima,(unknown),Hadrian Szpurka,Mikkael A. Sekeres,Xiaofei Wang,Michael A. McDevitt,Jaroslaw P. Maciejewski	223
18	Chemokine system and tissue infiltration in aggressive NK-cell leukemia 2006 ·Leukemia Research ·Hideki Makishima,Toshiro Ito,(unknown),Hideyuki Nakazawa,Shigetaka Shimodaira,Yuji Kamijo,Yozo Nakazawa,Naoaki Ichikawa,(unknown),Hikaru Kobayashi,Kiyoshi Kitano,Hiroshi Saito,Kendo Kiyosawa,Fumihiro Ishida	26
19	DNA microarray analysis of natural killer cell-type lymphoproliferative disease of granular lymphocytes with purified CD3−CD56+ fractions 2004 ·Leukemia ·Young-Lim Choi,Hideki Makishima,Jun Ohashi,Yumi Yamashita,Ruri Ohki,Koji Koinuma,Jun Ota,Yasushi Isobe,Fumihiro Ishida,Kazuo Oshimi,Hiroyuki Mano	19
20	A case of primary cardiac lymphoma: Utility of serum soluble interleukin-2 receptor for noninvasive diagnosis 1998 ·International Journal of Cardiology ·Hideki Makishima,Mitsuaki Isobe,Hiroshi Imamura	14

About Hideki Makishima

Hideki Makishima is a scholar working on Hematology, Genetics and Immunology, having authored 134 papers that have together received 4.0k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (94 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (37 papers) and Chronic Myeloid Leukemia Treatments (21 papers). The work is most often cited by research in Hematology (2.5k citations), Genetics (1.4k citations) and Immunology (658 citations). Hideki Makishima has collaborated with scholars based in United States, Japan and Germany. Frequent co-authors include Jaroslaw P. Maciejewski, Mikkael A. Sekeres, Ramón V. Tiu, Christine L. O’Keefe, Hadrian Szpurka, Michael A. McDevitt, Bartlomiej Przychodzen, Valeria Visconte, A. Jankowska and Manuel Afable. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and The Journal of Experimental Medicine.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact